Comparative genomic hybridization of fine needle aspirates from breast carcinomas

Nicole G. Bürki, Rosmarie Caduff, Heinrich Walt, Carlo Moll, Tanja Pejovic, Urs Haller, David C. Ward

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Detailed knowledge of chromosomal aberrations in a specific tumor may facilitate the development of individually tailored chemotherapy, hormone or gene therapy. Unfortunately, karyotype analysis requires living cells and is complicated by the low number of good metaphase spreads obtained. Comparative genomic hybridization (CGH), however, is capable of detecting and mapping genome-wide amplifications and deletions using an equimolar mixture of normal and tumor cell DNA. We show here that even the few cells from a fine needle aspirate of a tumor are sufficient for a direct CGH assay, independent of DNA amplification. Ten primary breast cancers were analyzed by CGH. A fresh frozen fine needle aspirate and a formalin-fixed and paraffin-embedded section were used for each tumor. Metaphases from each CGH reaction were imaged, and a sum ratio profile was determined for every chromosome. The ratio profiles of DNA isolated from the 2 material sources were then compared. Fine needle aspirates and the paraffin-embedded material of a single tumor yielded the same fluorescence ratio profiles, albeit with slightly different confidence intervals. Different tumors showed a variety of aberrations. The most frequently observed changes were 1q+, 8q+, 14q-, 16p+, 16q-, 17p-, 17q+, 19q+, 20q+, 21q- and 22q-. The ability of CGH to assess chromosomal changes in breast cancer from fine needle aspirates could facilitate genetic evaluation of tumors prior to surgery. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)607-613
Number of pages7
JournalInternational Journal of Cancer
Volume88
Issue number4
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Comparative Genomic Hybridization
Needles
Breast Neoplasms
Neoplasms
Metaphase
Paraffin
DNA
Chromosome Mapping
Karyotype
Chromosome Aberrations
Genetic Therapy
Formaldehyde
Chromosomes
Fluorescence
Hormones
Confidence Intervals
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Comparative genomic hybridization of fine needle aspirates from breast carcinomas. / Bürki, Nicole G.; Caduff, Rosmarie; Walt, Heinrich; Moll, Carlo; Pejovic, Tanja; Haller, Urs; Ward, David C.

In: International Journal of Cancer, Vol. 88, No. 4, 2000, p. 607-613.

Research output: Contribution to journalArticle

Bürki, Nicole G. ; Caduff, Rosmarie ; Walt, Heinrich ; Moll, Carlo ; Pejovic, Tanja ; Haller, Urs ; Ward, David C. / Comparative genomic hybridization of fine needle aspirates from breast carcinomas. In: International Journal of Cancer. 2000 ; Vol. 88, No. 4. pp. 607-613.
@article{3a665624f0af4ea1a48dff6a012863d3,
title = "Comparative genomic hybridization of fine needle aspirates from breast carcinomas",
abstract = "Detailed knowledge of chromosomal aberrations in a specific tumor may facilitate the development of individually tailored chemotherapy, hormone or gene therapy. Unfortunately, karyotype analysis requires living cells and is complicated by the low number of good metaphase spreads obtained. Comparative genomic hybridization (CGH), however, is capable of detecting and mapping genome-wide amplifications and deletions using an equimolar mixture of normal and tumor cell DNA. We show here that even the few cells from a fine needle aspirate of a tumor are sufficient for a direct CGH assay, independent of DNA amplification. Ten primary breast cancers were analyzed by CGH. A fresh frozen fine needle aspirate and a formalin-fixed and paraffin-embedded section were used for each tumor. Metaphases from each CGH reaction were imaged, and a sum ratio profile was determined for every chromosome. The ratio profiles of DNA isolated from the 2 material sources were then compared. Fine needle aspirates and the paraffin-embedded material of a single tumor yielded the same fluorescence ratio profiles, albeit with slightly different confidence intervals. Different tumors showed a variety of aberrations. The most frequently observed changes were 1q+, 8q+, 14q-, 16p+, 16q-, 17p-, 17q+, 19q+, 20q+, 21q- and 22q-. The ability of CGH to assess chromosomal changes in breast cancer from fine needle aspirates could facilitate genetic evaluation of tumors prior to surgery. (C) 2000 Wiley-Liss, Inc.",
author = "B{\"u}rki, {Nicole G.} and Rosmarie Caduff and Heinrich Walt and Carlo Moll and Tanja Pejovic and Urs Haller and Ward, {David C.}",
year = "2000",
doi = "10.1002/1097-0215(20001115)88:4<607::AID-IJC14>3.0.CO;2-3",
language = "English (US)",
volume = "88",
pages = "607--613",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Comparative genomic hybridization of fine needle aspirates from breast carcinomas

AU - Bürki, Nicole G.

AU - Caduff, Rosmarie

AU - Walt, Heinrich

AU - Moll, Carlo

AU - Pejovic, Tanja

AU - Haller, Urs

AU - Ward, David C.

PY - 2000

Y1 - 2000

N2 - Detailed knowledge of chromosomal aberrations in a specific tumor may facilitate the development of individually tailored chemotherapy, hormone or gene therapy. Unfortunately, karyotype analysis requires living cells and is complicated by the low number of good metaphase spreads obtained. Comparative genomic hybridization (CGH), however, is capable of detecting and mapping genome-wide amplifications and deletions using an equimolar mixture of normal and tumor cell DNA. We show here that even the few cells from a fine needle aspirate of a tumor are sufficient for a direct CGH assay, independent of DNA amplification. Ten primary breast cancers were analyzed by CGH. A fresh frozen fine needle aspirate and a formalin-fixed and paraffin-embedded section were used for each tumor. Metaphases from each CGH reaction were imaged, and a sum ratio profile was determined for every chromosome. The ratio profiles of DNA isolated from the 2 material sources were then compared. Fine needle aspirates and the paraffin-embedded material of a single tumor yielded the same fluorescence ratio profiles, albeit with slightly different confidence intervals. Different tumors showed a variety of aberrations. The most frequently observed changes were 1q+, 8q+, 14q-, 16p+, 16q-, 17p-, 17q+, 19q+, 20q+, 21q- and 22q-. The ability of CGH to assess chromosomal changes in breast cancer from fine needle aspirates could facilitate genetic evaluation of tumors prior to surgery. (C) 2000 Wiley-Liss, Inc.

AB - Detailed knowledge of chromosomal aberrations in a specific tumor may facilitate the development of individually tailored chemotherapy, hormone or gene therapy. Unfortunately, karyotype analysis requires living cells and is complicated by the low number of good metaphase spreads obtained. Comparative genomic hybridization (CGH), however, is capable of detecting and mapping genome-wide amplifications and deletions using an equimolar mixture of normal and tumor cell DNA. We show here that even the few cells from a fine needle aspirate of a tumor are sufficient for a direct CGH assay, independent of DNA amplification. Ten primary breast cancers were analyzed by CGH. A fresh frozen fine needle aspirate and a formalin-fixed and paraffin-embedded section were used for each tumor. Metaphases from each CGH reaction were imaged, and a sum ratio profile was determined for every chromosome. The ratio profiles of DNA isolated from the 2 material sources were then compared. Fine needle aspirates and the paraffin-embedded material of a single tumor yielded the same fluorescence ratio profiles, albeit with slightly different confidence intervals. Different tumors showed a variety of aberrations. The most frequently observed changes were 1q+, 8q+, 14q-, 16p+, 16q-, 17p-, 17q+, 19q+, 20q+, 21q- and 22q-. The ability of CGH to assess chromosomal changes in breast cancer from fine needle aspirates could facilitate genetic evaluation of tumors prior to surgery. (C) 2000 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0033756274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033756274&partnerID=8YFLogxK

U2 - 10.1002/1097-0215(20001115)88:4<607::AID-IJC14>3.0.CO;2-3

DO - 10.1002/1097-0215(20001115)88:4<607::AID-IJC14>3.0.CO;2-3

M3 - Article

C2 - 11058878

AN - SCOPUS:0033756274

VL - 88

SP - 607

EP - 613

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -